| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.02 |